⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VTRS

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

16.50USD

-0.1100 (-0.66%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24
Revenue3,7463,5103,6913,7483,5693,2433,5153,738
Cost of Revenue2,3002,3602,5562,3882,2492,0932,3132,292
Gross Profit1,4571,1571,1481,3721,3331,1611,2151,459
Operating Income6-80-193179233-2,882-180226
Net Income————————
EPS (Diluted)$-0.10$0.15$-0.30$-0.11$0.00$-2.55$-0.43$0.08

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)